Sanofi (SNY) reported Q2 earnings Thursday of 3.24 euros ($3.71) per share, up from 0.89 euro a year earlier.
Net sales for the quarter ended June 30 were 9.99 billion euros, up from 9.43 billion euros a year earlier.
For 2025, the company said it now expects sales to grow by a high single-digit percentage at CER versus its prior outlook of mid-to-high single-digit.
Sanofi shares were down 4.6% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.